Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An update from Hookipa Pharma ( (HOOK) ) is now available.
HOOKIPA Pharma Inc. filed a petition in the Delaware Court of Chancery on December 27, 2024, to validate actions taken during its 2022 and 2023 Annual Stockholder Meetings. These actions include the approval of director elections and amendments to the company’s certificate of incorporation and stock option plan. The company is seeking validation due to incorrect record dates set for these meetings, which contravened the Delaware General Corporation Law. The Court of Chancery has approved an expedited proceeding, with a final hearing scheduled for February 14, 2025, where stockholders can express their positions.
More about Hookipa Pharma
YTD Price Performance: 0.51%
Average Trading Volume: 133,158
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $19.39M
See more insights into HOOK stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue